In Situ Cross-Linked Chitosan/Hyaluronic Acid Hydrogel for Removing Kidney Stone Fragments after Lithotripsy Surgery
ACS Applied Bio Materials · 2025
DOI: 10.1021/acsabm.5c01297 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2025. Verfasst von Ning Qian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Advanced Materials and Joint International Research Laboratory of Precision Chemistry and Molecular Engineering, Feringa Nobel Pri…. Hauptthemen laut MEDLINE: Hyaluronic Acid, Kidney Calculi, Hydrogels, Chitosan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory for Advanced Materials and Joint International Research Laboratory of Precision Chemistry and Molecular Engineering, Feringa Nobel Prize Scientist Joint Research Center, School of Chemistry and Molecular…
- Minhang Hospital, Fudan University, 170 Xinsong Road, Shanghai 201199, China.
- Department of Center Laboratory, Punan Branch of Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200125, China.
ORCID-Profile: Yu Chen
Zitieren
APA
Qian, N., He, M., Wang, K., He, C., & Chen, Y. (2025). In Situ Cross-Linked Chitosan/Hyaluronic Acid Hydrogel for Removing Kidney Stone Fragments after Lithotripsy Surgery. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.5c01297
Vancouver
Qian N, He M, Wang K, He C, Chen Y. In Situ Cross-Linked Chitosan/Hyaluronic Acid Hydrogel for Removing Kidney Stone Fragments after Lithotripsy Surgery. ACS Applied Bio Materials. 2025. doi:10.1021/acsabm.5c01297
BibTeX
@article{Qian2025,
author = {Qian, Ning and He, Minke and Wang, Kexin and He, Chang and Chen, Yu},
title = {In Situ Cross-Linked Chitosan/Hyaluronic Acid Hydrogel for Removing Kidney Stone Fragments after Lithotripsy Surgery},
journal = {ACS Applied Bio Materials},
year = {2025},
doi = {10.1021/acsabm.5c01297}
}
EUVIMED